Filtered By:
Vaccination: Shingles (Herpes Zoster) Vaccine
This page shows you your search results in order of relevance. This is page number 4.
Order by Relevance | Date
Total 2063 results found since Jan 2013.
Survey of Physician Practices, Attitudes, and Knowledge Regarding Recombinant Zoster Vaccine
CONCLUSION: Most primary care physicians welcome updated ACIP RZV recommendations for immunocompromised adults. Knowledge gaps, communication issues, and financial barriers need to be addressed to optimize vaccination delivery.PMID:35794307 | PMC:PMC9261227 | DOI:10.1007/s11606-022-07721-z
Source: Topics in HIV Medicine - July 6, 2022 Category: Infectious Diseases Authors: Laura P Hurley Sean T O'Leary Kathleen Dooling Tara C Anderson Lori A Crane Jessica R Cataldi Michaela Brtnikova Brenda L Beaty Carol Gorman Angela Guo Megan C Lindley Allison Kempe Source Type: research
Epidemiology of Pediatric Herpes Zoster After Varicella Infection: A Population-Based Study
CONCLUSIONS:
This study demonstrates the population-based epidemiologic characteristics of pediatric HZ among those who contracted varicella. In the early postvaricella vaccination period, an increased HZ incidence was observed among children with varicella infection aged ≥2 years.
Source: PEDIATRICS - March 2, 2015 Category: Pediatrics Authors: Wen, S.-Y., Liu, W.-L. Tags: Article Source Type: research
Chicken pox vaccine linked with shingles at the vaccination site in some children
(Wiley) New research in Pediatric Dermatology reports several cases of shingles that developed at the original vaccination site in healthy children after they were immunized against chicken pox.
Source: EurekAlert! - Medicine and Health - February 9, 2018 Category: International Medicine & Public Health Source Type: news
Survey of Physician Practices, Attitudes, and Knowledge Regarding Recombinant Zoster Vaccine
CONCLUSION: Most primary care physicians welcome updated ACIP RZV recommendations for immunocompromised adults. Knowledge gaps, communication issues, and financial barriers need to be addressed to optimize vaccination delivery.PMID:35794307 | DOI:10.1007/s11606-022-07721-z
Source: Topics in HIV Medicine - July 6, 2022 Category: Infectious Diseases Authors: Laura P Hurley Sean T O'Leary Kathleen Dooling Tara C Anderson Lori A Crane Jessica R Cataldi Michaela Brtnikova Brenda L Beaty Carol Gorman Angela Guo Megan C Lindley Allison Kempe Source Type: research
An Unusual Case of Arm Pain in a Young Soccer Player: Herpes Zoster in the Pediatric Athlete
Herpes zoster (HZ), shingles, is caused by the varicella-zoster virus (VZV). HZ develops as a reactivation of latent VZV and is characterized by a painful, vesicular rash typically manifesting in a dermatomal distribution on the arms, trunk or face. HZ occurs in individuals who had primary VZV disease (chickenpox) as a child or in those who have received live, attenuated VZV vaccine. HZ is common in the elderly and the immunocompromised, with age being the single greatest risk factor. The incidence of HZ in children is 74/100,000 person years for the unvaccinated and 38/100,000 person years for the vaccinated. We discuss t...
Source: Current Sports Medicine Reports - November 1, 2022 Category: Sports Medicine Tags: Case Reports Source Type: research
Lower dementia risk in patients vaccinated against herpes zoster
Conclusions: Among patients ≥65 years of age, HZ vaccination is associated with a 31-35% reduced risk of dementia. Confirmation in other study designs is warranted. Results may be explained by nonspecific neuroprotection and vaccination training the immune system to limit damaging inflammation. Results highlight the importance of HZ vaccination.PMID:36696249 | DOI:10.1370/afm.20.s1.2680
Source: Annals of Family Medicine - January 25, 2023 Category: Primary Care Authors: Jeffrey Scherrer Joanne Salas Christine Jacobs Timothy Wiemken Source Type: research
Impact of Health Insurance Status on Vaccination Coverage Among Adult Populations
Conclusions Overall, vaccination coverage among adults aged ≥18 years is lower among uninsured populations. Implementation of effective strategies is needed to help improve vaccination coverage among adults aged ≥18 years, especially those without health insurance.
Source: American Journal of Preventive Medicine - April 29, 2015 Category: Global & Universal Source Type: research
Summer 2015 Update: ACIP Adult Vaccine Recommendations Summer 2015 Update: ACIP Adult Vaccine Recommendations
Highlights of the June 2015 ACIP meeting and recommendations for meningococcal B, flu, and pneumococcal vaccines. Also: Informational updates for Tdap and herpes zoster vaccine. Medscape Internal Medicine
Source: Medscape Today Headlines - July 13, 2015 Category: Consumer Health News Tags: Family Medicine/Primary Care Expert Column Source Type: news
Challenges in adult vaccination.
This article introduces the technical, economic, political and demographic issues that make establishing effective adult vaccination programs such a difficult, but pressing issue, and outlines some of the steps that are now being taken to address them. Key messages Life-long preventive activities that start and continue throughout life are essential, especially as the world's population is "getting older". This "Healthy aging" approach includes not only healthy diet and physical exercise; vaccination is critical in reducing some infectious diseases and their complications. Many adults, especially older adults (who have low...
Source: Annals of Medicine - January 18, 2018 Category: Internal Medicine Tags: Ann Med Source Type: research
Epidemiology of Pediatric Herpes Zoster After Varicella Infection: A Population-Based Study
This is the first population-based study regarding the epidemiologic characteristics of pediatric zoster among only those who had contracted varicella.
The herpes zoster (HZ) incidence among only children with varicella infection is higher than previously reported. The HZ incidence increased for children contracting varicella aged <2 years. After a vaccination program, the HZ risk increased for those contracting varicella aged ≥2 years. (Read the full article)
Source: PEDIATRICS - March 2, 2015 Category: Pediatrics Tags: Pediatrics Digest Summary Source Type: research
Herpes zoster at the vaccination site in immunized healthy children
Pediatric Dermatology,Volume 35, Issue 2, Page 230-233, March/April 2018.
Source: Pediatric Dermatology - February 6, 2018 Category: Dermatology Source Type: research
Varicella infection in an immunized pediatric living donor liver-transplant recipient
Vibha Mehta, Krithiga Ramachandran, Reshu Agarwal, Seema Alam, Viniyendra Pamecha, Ekta GuptaJournal of Global Infectious Diseases 2021 13(3):142-144
Varicella-zoster virus (VZV) is a DNA virus belonging to the Herpesviridae family. Primary infection causes chickenpox followed by latency in the sensory ganglia, which can sometimes reactivate leading to herpes zoster. Chicken pox is generally a mild disease of childhood with a secondary attack rate of >85%, but disseminated VZV infection with visceral involvement and fatal outcome may occur in immunocompromised individuals. Indian Academy of Pediatric...
Source: Journal of Global Infectious Diseases - August 31, 2021 Category: Infectious Diseases Authors: Vibha Mehta Krithiga Ramachandran Reshu Agarwal Seema Alam Viniyendra Pamecha Ekta Gupta Source Type: research
Development of Herpes Zoster Ophthalmicus in an Immunocompetent Pediatric Patient Following Facial Trauma
Herpes zoster ophthalmicus (HZO) is a neuro-oculo-dermic infection caused by reactivation of latent varicella zoster virus in the dorsal root ganglia of the ophthalmic division of the trigeminal nerve. Although a rare diagnosis in an otherwise healthy, vaccinated pediatric patient, this entity may occur with increasing frequency among those with preceding trauma, particularly in the month prior to presentation. Herein, we highlight a case of HZO in a vaccinated, immunocompetent adolescent in the setting of recent facial trauma.
Source: Ophthalmic Plastic and Reconstructive Surgery - September 1, 2021 Category: Opthalmology Tags: Case Reports Source Type: research
Factors associated with pneumococcal vaccine uptake among vulnerable older adults in the United States primary care setting
This study assessed factors associated with having gotten a pneumococcal vaccine among vulnerable adults aged 50 and older. This study used the 2018 Medical Expenditure Panel Survey nationally representative dataset. Eligible individuals were aged 50-64 with an 'at risk' health condition or ≥65 years and had a primary care provider as their usual source of care (N = 3,760). Binary logistic regression was used to test factors (identified from literature) for a significant association with getting the pneumococcal vaccine. Factors with significant associations were entered into an adjusted multivariable logistic regression...
Source: Vaccine - October 13, 2022 Category: Allergy & Immunology Authors: Megan Whaley David R Axon Source Type: research
